Infinity Pharmaceuticals, Inc. Restructuring and Related Cost, Incurred Cost
Infinity Pharmaceuticals, Inc. reported Restructuring and Related Cost, Incurred Cost of $1.71 million for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringAndRelatedCostIncurredCost · last filed 2023-08-10
- Infinity Pharmaceuticals, Inc. restructuring and related cost, incurred cost for the quarter ending 2023-06-30 was -$12.00K.
- Infinity Pharmaceuticals, Inc. restructuring and related cost, incurred cost for the quarter ending 2023-03-31 was $1.72M.
- Infinity Pharmaceuticals, Inc. restructuring and related cost, incurred cost for the quarter ending 2017-12-31 was $0.00, a 100.00% decline year-over-year.
- Infinity Pharmaceuticals, Inc. restructuring and related cost, incurred cost for the quarter ending 2017-09-30 was $0.00, a 100.00% decline year-over-year.
- Infinity Pharmaceuticals, Inc. restructuring and related cost, incurred cost for fiscal 2017 was $15.00K, a 99.93% decline from fiscal 2016.
- Infinity Pharmaceuticals, Inc. restructuring and related cost, incurred cost for fiscal 2016 was $21.20M.
- Infinity Pharmaceuticals, Inc. restructuring and related cost, incurred cost for fiscal 2012 was -$2.58M.
| Period end | Restructuring and Related Cost, Incurred Cost 3 month | Restructuring and Related Cost, Incurred Cost 6 month | Restructuring and Related Cost, Incurred Cost 6 month as first filed | Restructuring and Related Cost, Incurred Cost 9 month | Restructuring and Related Cost, Incurred Cost 12 month | Restructuring and Related Cost, Incurred Cost 12 month as first filed |
|---|---|---|---|---|---|---|
| 2023-06-30 | -$12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $1.71M 10-Q · filed 2023-08-10 | ||||
| 2023-03-31 | $1.72M 10-Q · filed 2023-05-09 | |||||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $0.00 derived: sum of 2 quarters · filed 2018-03-15 | $0.00 derived: sum of 3 quarters · filed 2018-03-15 | $15.00K 10-K · filed 2018-03-15 | ||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $0.00 derived: sum of 2 quarters · filed 2017-11-07 | $15.00K 10-Q · filed 2017-11-07 | $4.29M derived: sum of 4 quarters · filed 2018-03-15 | ||
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $15.00K 10-Q · filed 2017-08-03 | $4.29M derived: sum of 3 quarters · filed 2018-03-15 | $21.19M derived: sum of 4 quarters · filed 2018-03-15 | ||
| 2017-03-31 | $15.00K 10-Q · filed 2017-05-09 | $4.29M derived: sum of 2 quarters · filed 2018-03-15 | $21.19M derived: sum of 3 quarters · filed 2018-03-15 | $37.79M derived: sum of 4 quarters · filed 2018-03-15 | ||
| 2016-12-31 | $4.28M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $21.18M derived: sum of 2 quarters · filed 2018-03-15 | $37.78M derived: sum of 3 quarters · filed 2018-03-15 | $21.20M 10-K · filed 2018-03-15 | $21.18M 10-K · filed 2017-03-14 | |
| 2016-09-30 | $16.90M 10-Q · filed 2017-11-07 | $33.50M derived: sum of 2 quarters · filed 2017-11-07 | $16.92M 10-Q · filed 2016-11-09 | |||
| 2016-06-30 | $16.60M 10-Q · filed 2017-08-03 | $16.60M 10-Q · filed 2017-08-03 | $16.64M 10-Q · filed 2016-08-09 | |||
| 2012-12-31 | -$2.58M 10-K · filed 2013-03-05 |